Androgen-Induced Secondary Hypogonadism and Associated Erectile Dysfunction in Recreational Weightlifters: A Narrative Review
DOI:
https://doi.org/10.12775/QS.2026.56.72517Keywords
anabolic androgenic steroid, secondary hypogonadism, erectile dysfunction, bodybuilding, ASIHAbstract
Background. Anabolic-androgenic steroid (AAS) abuse is extremely common among amateur athletes and bodybuilders seeking to improve their physical appearance and performance. Chronic use of these substances in supraphysiological doses leads to severe suppression of the hypothalamic-pituitary-testicular (HPT) axis, resulting in anabolic steroid-induced hypogonadism (ASIH).
Aim. This work aims to summarize the current knowledge and available scientific evidence regarding the effects of AAS abuse on the male reproductive system, with particular emphasis on the mechanisms of secondary hypogonadism and erectile dysfunction in amateur bodybuilders.
Material and Methods. A comprehensive review of the medical literature was conducted, including available clinical trials, observational studies, meta-analyses, and case reports of men using or abusing AAS. The analysis assessed hormonal parameters (FSH, LH, total testosterone), semen parameters, sexual function, and the patterns and time to reversal of these changes after steroid discontinuation.
Results. Chronic AAS abuse profoundly suppresses the secretion of endogenous gonadotropins (LH and FSH), leading to a drastic decrease in intratesticular testosterone and secondary hypogonadism. Men often report sexual dysfunction, particularly during the withdrawal period (so-called "post-cycle"), with erectile dysfunction and decreased sexual desire observed in between 10% and over 30% of them.
Conclusions. Secondary hypogonadism and erectile dysfunction are significant yet underestimated consequences of AAS abuse in amateur bodybuilding. Although hormonal parameters and sexual function return to normal in most patients after discontinuing doping, this process can be lengthy and often requires individualized medical intervention, such as the use of human chorionic gonadotropin (hCG) or selective estrogen receptor modulators (SERMs), to accelerate recovery of the HPG axis.
References
Albano GD, Amico F, Cocimano G, Liberto A, Maglietta F, Esposito M, Rosi GL, Di Nunno N, Salerno M, Montana A. Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review. Healthcare (Basel). 2021 Jan 19;9(1):97. doi: 10.3390/healthcare9010097. PMID: 33477800; PMCID: PMC7832337. https://doi.org/10.3390/healthcare9010097
Bond P, Smit DL, de Ronde W. Anabolic-androgenic steroids: How do they work and what are the risks? Front Endocrinol (Lausanne). 2022 Dec 19;13:1059473. doi: 10.3389/fendo.2022.1059473. PMID: 36644692; PMCID: PMC9837614. https://doi.org/10.3389/fendo.2022.1059473
Casey RW, Wilson JD. Antiestrogenic action of dihydrotestosterone in mouse breast. Competition with estradiol for binding to the estrogen receptor. J Clin Invest. 1984 Dec;74(6):2272-8. doi: 10.1172/JCI111654. PMID: 6542571; PMCID: PMC425420.
https://doi.org/10.1172/JCI111654
De Ronde W, Smit DL. Anabolic androgenic steroid abuse in young males. Endocr Connect. 2020 Apr;9(4):R102-R111. doi: 10.1530/EC-19-0557. PMID: 32229704; PMCID: PMC7219134. https://doi.org/10.1530/EC-19-0557
Ding JB, Ng MZ, Huang SS, Ding M, Hu K. Anabolic-Androgenic Steroid Misuse: Mechanisms, Patterns of Misuse, User Typology, and Adverse Effects. J Sports Med (Hindawi Publ Corp). 2021 Dec 10;2021:7497346. PMID: 34926695; PMCID:PMC8683244. https://doi.org/10.1155/2021/7497346
Finkelstein JS, Lee H, Burnett-Bowie SA, Pallais JC, Yu EW, Borges LF, Jones BF, Barry CV, Wulczyn KE, Thomas BJ, Leder BZ. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013 Sep 12;369(11):1011-22. doi: 10.1056/NEJMoa1206168. PMID: 24024838; PMCID: PMC4142768. https://doi.org/10.1056/NEJMoa1206168
Giovanni Corona, Giulia Rastrelli, Sara Marchiani, Sandra Filippi, Annamaria Morelli, Erica SarchielliConsequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective World J Mens Health. 2022 Apr;40(2):165-178. https://doi.org/10.5534/wjmh.210021
Grant B, Kean J, Vali N, Campbell J, Maden L, Bijral P, Dhillo WS, McVeigh J, Quinton R, Jayasena CN. The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men. Subst Abuse Treat Prev Policy. 2023 Nov 11;18(1):66. doi: 10.1186/s13011-023-00573-8. PMID: 37951896; PMCID: PMC10640727. https://doi.org/10.1186/s13011-023-00573-8
Hashimi MA, Pinggera GM, Shah R, Agarwal A. Clinician's guide to the management of azoospermia induced by exogenous testosterone or anabolic-androgenic steroids. Asian J Androl. 2025 May 1;27(3):330-341. doi: 10.4103/aja2024104. Epub 2025 Jan 17. PMID: 39820213; PMCID: PMC12112917. https://doi.org/10.4103/aja2024104
Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol. 2008 Jun;154(3):502-21. doi: 10.1038/bjp.2008.165. PMID: 18500378; PMCID: PMC2439524. https://doi.org/10.1038/bjp.2008.165
Lakshman KM, Kaplan B, Travison TG, Basaria S, Knapp PE, Singh AB, LaValley MP, Mazer NA, Bhasin S. The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab. 2010 Aug;95(8):3955-64. doi: 10.1210/jc.2010-0102. Epub 2010 Jun 9. PMID: 20534765; PMCID: PMC2913038. https://doi.org/10.1210/jc.2010-0102
Longcope C, Kato T, Horton R. Conversion of blood androgens to estrogens in normal adult men and women. J Clin Invest. 1969 Dec;48(12):2191-201. doi: 10.1172/JCI106185. PMID: 5355335; PMCID: PMC297476. https://doi.org/10.1172/JCI106185
Mulawkar PM, Maheshwari PN, Gauhar V, Agrawal SG, Mohammed TO, Singh AG, Tak GR, Shah US, Shukla DP, Mamankar D. Use of Anabolic-Androgenic Steroids and Male Fertility: A Systematic Review and Meta-analysis. J Hum Reprod Sci. 2023 Oct-Dec;16(4):268-285.Epub 2023 Dec 29. PMID: 38322636; PMCID: PMC10841926. https://doi.org/10.4103/jhrs.jhrs_90_23
Rosner W, Deakins SM. Testosterone-binding globulins in human plasma: studies on sex distribution and specificity. J Clin Invest. 1968 Sep;47(9):2109-16. doi: 10.1172/JCI105896. PMID: 4175320; PMCID: PMC297371. https://doi.org/10.1172/JCI105896
Rossi BV, Abusief M, Missmer SA. Modifiable Risk Factors and Infertility: What are the Connections? Am J Lifestyle Med. 2014;10(4):220-231. doi: 10.1177/1559827614558020. Epub 2014 Dec 16. PMID: 27594813; PMCID: PMC5007064. https://doi.org/10.1177/1559827614558020
Roth MY, Lin K, Amory JK, Matsumoto AM, Anawalt BD, Snyder CN, Kalhorn TF, Bremner WJ, Page ST. Serum LH correlates highly with intratesticular steroid levels in normal men. J Androl. 2010 Mar-Apr;31(2):138-45. doi: 10.2164/jandrol.109.008391. Epub 2009 Sep 24. PMID: 19779211; PMCID: PMC2866133. https://doi.org/10.2164/jandrol.109.008391
Sansone A, Sansone M, Vaamonde D, Sgrò P, Salzano C, Romanelli F, Lenzi A, Di Luigi L. Sport, doping and male fertility. Reprod Biol Endocrinol. 2018 Nov 12;16(1):114. doi: 10.1186/s12958-018-0435-x. PMID: 30415644; PMCID: PMC6231265. https://doi.org/10.1186/s12958-018-0435-x
Skorupskaite K, George JT, Anderson RA. The kisspeptin-GnRH pathway in human reproductive health and disease. Hum Reprod Update. 2014 Jul-Aug;20(4):485-500. doi: 10.1093/humupd/dmu009. Epub 2014 Mar 9. PMID: 24615662; PMCID: PMC4063702. https://doi.org/10.1093/humupd/dmu009
Solanki P, Eu B, Smith J, Allan C, Lee K. Physical, psychological and biochemical recovery from anabolic steroid-induced hypogonadism: a scoping review. Endocr Connect. 2023 Oct 19;12(12):e230358. doi: 10.1530/EC-23-0358. PMID: 37855241; PMCID: PMC10620455. https://doi.org/10.1530/EC-23-0358
Swerdloff RS, Dudley RE, Page ST, Wang C, Salameh WA. Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels. Endocr Rev. 2017 Jun 1;38(3):220-254. doi: 10.1210/er.2016-1067. PMID: 28472278; PMCID: PMC6459338. https://doi.org/10.1210/er.2016-1067
Tauchen J, Jurášek M, Huml L, Rimpelová S. Medicinal Use of Testosterone and Related Steroids Revisited. Molecules. 2021 Feb 15;26(4):1032. doi: 10.3390/molecules26041032. PMID: 33672087; PMCID: PMC7919692. https://doi.org/10.3390/molecules26041032
Tirla A, Vesa CM, Cavalu S. Severe Cardiac and Metabolic Pathology Induced by Steroid Abuse in a Young Individual. Diagnostics (Basel). 2021 Jul 21;11(8):1313. doi: 10.3390/diagnostics11081313. PMID: 34441248; PMCID: PMC8394374. https://doi.org/10.3390/diagnostics11081313
Wood RI, Stanton SJ. Testosterone and sport: current perspectives. Horm Behav. 2012 Jan;61(1):147-55. doi: 10.1016/j.yhbeh.2011.09.010. Epub 2011 Oct 1. PMID: 21983229; PMCID: PMC3264812. https://doi.org/10.1016/j.yhbeh.2011.09.010
PAJĄK, Monika, GRUŻEWSKA-PIOTROWSKA, Kinga, HUBKA, Joanna and GRUŻEWSKA, Agnieszka. Side effects of anabolic-androgenic steroids abuse – empirical research based on anonymous surveys among people who regularly attend the gym. Quality in Sport. https://doi.org/10.12775/QS.2023.14.01.008
DOROBEK, Wioleta, SZEREJ, Krzysztof, WALCZAK, Dawid, STANKIEWICZ, Katarzyna and ŚWIECZKOWSKI-FEIZ, Janusz. Impact of anabolic steroids on male fertility and the role of post-cycle therapy in recovery. Journal of Education, Health and Sport. Impact of anabolic steroids on male fertility and the role of post-cycle therapy in recovery. https://doi.org/10.12775/JEHS.2024.57.013
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Alesia Kravets, Lizaveta Zhukava, Kateryna Bessmylna, Agata Chrobak, Abdulrahman Alansi, Kai-Chiun Weng, Joanna Katarzyna Żukowska, Darya Volkava, Volha Sakovich, Ewa Kacynel, Wiktoria Myślicka

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 10
Number of citations: 0